Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge
Allergy2013Vol. 68(7), pp. 938–944
Citations Over TimeTop 10% of 2013 papers
Soo‐Young Yoon, So Yeon Park, S. Kim, Taehoon Lee, Y. S. Lee, Hyuk‐Sang Kwon, Y. S. Cho, Hee‐Bom Moon, Tae‐Bum Kim
Abstract
Routine skin testing with a cephalosporin before its administration is not useful for predicting immediate hypersensitivity because of the extremely low sensitivity and PPV of the skin test (CRIS registration no. KCT0000455).
Related Papers
- → Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime(2013)39 cited
- → Comparison of Ceftriaxone versus Cefotaxime for Childhood Upper Urinary Tract Infections(1996)10 cited
- Susceptibility of clinical isolates to cephalexin, cefazolin and cefotaxime.(1989)
- → Ceftriaxone versus Cefotaxime in the Treatment of Septicemia in Adults(1989)3 cited
- [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].(1986)